Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Emerge Bioscience is a biotechnology company based in Kalamazoo, Michigan, dedicated to the advancement of plant-derived therapeutics. The company focuses on the research and development of high-purity cannabinoid compounds targeting the endocannabinoid system to treat conditions such as chronic pain and inflammation. Emerge Bioscience utilizes a proprietary platform for the formulation and delivery of these compounds, ensuring enhanced bioavailability and standardized dosing. Their approach combines traditional phytochemistry with modern pharmacological standards to bridge the gap between natural products and pharmaceutical-grade medicines. The company provides both internal drug discovery programs and specialized ingredients for partners in the life sciences industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Emerge Bioscience.